Sign in
ZEOX Stock Price, Chart, Stats & News
Zeo ScientifiX, Inc.
Save
Zeo ScientifiX, Inc. (ZEOX) does not currently pay a dividend.
9.01M
Market cap
–
Current P/E
–
Forward P/E
ZEOX chart
About
Health care
Sector
Biotechnology
Industry
Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis.
Similar securities
Based on sector and market capitalization
Report issue